Advisory: Stray alert on Eiger Biopharmaceuticals withdrawn
29/06/2021 13:58
A stray alert on Eiger Biopharmaceuticals has been withdrawn as it was inadvertently issued. There will be no substiture. STORY_NUMBER: ASA02CG4 STORY_DATE: 29/06/2021 STORY_TIME: 12:00:13 ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview